AZ will invest £300m in UK, says PM Keir Starmer
AstraZeneca has delivered a much-needed boost to the UK government alongside a strong set of first-quarter results.
Newsletters and Deep Dive digital magazine
AstraZeneca has delivered a much-needed boost to the UK government alongside a strong set of first-quarter results.
When you attend events hosted by industry leaders like Google, you expect to be impressed by how technology continues to evolve.
Merck KGaA has started working with Remepy on the development of hybrid drugs that combine medicines with digital therapeutics.
AI start-up Profluent has signed a major alliance with pharma group Eli Lilly, worth up to $2.25bn, that will focus on gene-editing therapies.
A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
Editor's Picks
Newsletters and Deep Dive
digital magazine